Euro vs US Dollar

Registrieren Sie sich kostenlos, um Echtzeitkurse, interaktive Charts, Live-Optionsfluss und mehr zu erhalten.

Registrieren

COR Cencora Inc

254,58

0,81 (0,32%)

08 Mär 2025 - Geschlossen

Verzögert um 15 Minuten

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

Cencora (NYSE:COR)
Historical Stock Chart
Von Feb 2025 bis Mär 2025

Click Here for more Cencora Charts.

Cencora (NYSE:COR)
Historical Stock Chart
Von Mär 2024 bis Mär 2025

Click Here for more Cencora Charts.

News Cencora Inc

Form 4 - Statement of changes in beneficial ownership of securities
Dienstag 4 März 2025 (4 Tage vor) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Montag 3 März 2025 (5 Tage vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Freitag 28 Februar 2025 (1 Woche vor) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Donnerstag 27 Februar 2025 (1 Woche vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Montag 24 Februar 2025 (2 Wochen vor) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Freitag 21 Februar 2025 (2 Wochen vor) • Edgar (US Regulatory)

Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
Dienstag 11 Februar 2025 (4 Wochen vor) • Edgar (US Regulatory)

Form 8-K - Current report
Montag 10 Februar 2025 (4 Wochen vor) • Edgar (US Regulatory)

Cencora Announces Common Share Repurchase From Walgreens Boots Alliance
Freitag 7 Februar 2025 (1 Monat vor) • Business Wire

Form 144 - Report of proposed sale of securities
Freitag 7 Februar 2025 (1 Monat vor) • Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Mittwoch 5 Februar 2025 (1 Monat vor) • Edgar (US Regulatory)

Form 8-K - Current report
Mittwoch 5 Februar 2025 (1 Monat vor) • Edgar (US Regulatory)

Weitere Cencora Inc News-Artikel

Atossa Therapeutics

Texas Roadhouse

Bny Mellon US Large Cap ...

Genmab A S (PK)

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen